[LABP] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[LABP] Landos Biopharma, Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 29.54%
YoY- 36.82%
Quarter Report
LABP's Result
LABP's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 0 0 0 0 -
PBT -5,860 -7,896 -12,604 -8,230 -10.70%
Tax 0 67 191 -189 -
NP -5,860 -7,963 -12,604 -8,230 -10.70%
Tax Rate - - - - -
Total Cost 5,860 7,963 12,604 8,230 -10.70%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -0.94 -1.98 -3.20 -2.52 -28.01%
EPS Diluted -0.94 -1.98 -3.20 -2.52 -28.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.